Suppr超能文献

决定血压对转换酶抑制和钙通道阻滞反应的体液因素。

Humoral factors determining the blood pressure response to converting enzyme inhibition and calcium channel blockade.

作者信息

Evans R R, Davis W R, Wallace J M, DiPette D J, Holland O B

机构信息

Department of Internal Medicine, University of Texas Medical Branch, Galveston 77550.

出版信息

Am J Hypertens. 1990 Aug;3(8 Pt 1):605-10. doi: 10.1093/ajh/3.8.605.

Abstract

Renin and catecholamine levels were determined in patients with mild to moderate hypertension before and after treatment with sustained release diltiazem or captopril and were correlated with the blood pressure response to these antihypertensives. Eight weeks of treatment with either agent led to equal decreases in both systolic and diastolic blood pressure. Pretreatment plasma renin activity (PRA) and plasma norepinephrine did not predict the blood pressure response to either agent. Diltiazem significantly increased both PRA and supine norepinephrine levels. However, in the diltiazem treated patients, there was no correlation between the change in plasma norepinephrine and the change in systolic or diastolic blood pressure. In contrast, there was a negative correlation (P less than .05) between the reactive rise in PRA and the decrease in systolic blood pressure. Thus, the antihypertensive response to a calcium channel blocker may be determined, in part, by the reactive response of pressor systems.

摘要

测定了轻度至中度高血压患者在使用缓释地尔硫䓬或卡托普利治疗前后的肾素和儿茶酚胺水平,并将其与这些抗高血压药物的血压反应相关联。使用这两种药物中的任何一种进行八周治疗后,收缩压和舒张压均有同等程度的下降。治疗前的血浆肾素活性(PRA)和血浆去甲肾上腺素水平均不能预测对这两种药物的血压反应。地尔硫䓬显著升高了PRA和仰卧位去甲肾上腺素水平。然而,在接受地尔硫䓬治疗的患者中,血浆去甲肾上腺素的变化与收缩压或舒张压的变化之间没有相关性。相比之下,PRA的反应性升高与收缩压下降之间存在负相关(P小于0.05)。因此,对钙通道阻滞剂的抗高血压反应可能部分取决于升压系统的反应性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验